Journal of Clinical and Translational Hepatology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2022-09-21 Jessica0710

偏重的研究方向：肝癌
经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2022-06-21 编织手

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肝病
经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2021-11-19 ms6000000292023383

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：Hepatology;肝病;肝
经验分享：挺专业得

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2022-04-22 寺牧

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：分子免疫;药理
经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2022-04-07 ms1000000430162409

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肝病
经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高

79 0

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2022-04-07 ms1000000430162409

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肝病
经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2022-03-20 ms7000000507856696

审稿速度:12.0 | 投稿命中率:25.0
经验分享：对自己人不友好，典型崇洋媚外

107 0

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2021-11-26 浩曦

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：Hepatology
经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。

103 0

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2021-11-19 ms6000000292023383

偏重的研究方向：肝病HBL;肝病
经验分享：知名期刊!

50 0

[GetPortalCommentsPageByObjectIdResponse(id=2089489, encodeId=5751208948915, content=偏重的研究方向：肝癌 经验分享：我觉得还蛮快的，投稿三个月意见回来，大修，又认真补了实验，修回去两个星期就接受了。一共有两个审稿人意见，一个重研究大方向，一个重文章小细节，真的让我改了好多。不错的杂志，希望越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TGHb62ES8nArLgQwag2iapAVD36iaxOvUgdNIcSPfr6ia46pTnaB5l8mrhzY7oZhd6ribeQHC0NNBnCrOal1bOcYJg/132, createdBy=5c5c2031088, createdName=Jessica0710, createdTime=Wed Sep 21 09:46:08 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227800, encodeId=15c8122e8001c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：非常恶心人的杂志。修回后主编一票否决，问题非常无厘头。美籍华裔吴主编水平很差，提的是统计学上无法解决的问题。然后过了一个月发现，原来是我的题目跟他们自己人的题目撞了，SB杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=868d2190903, createdName=编织手, createdTime=Tue Jun 21 18:34:01 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071915, encodeId=4a1c10e19158d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：Hepatology;肝病;肝 经验分享：挺专业得, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:09:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213463, encodeId=d1051213463d0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子免疫;药理 经验分享：（综述）近三个月后大修，审稿人意见不一，主编认可，修回后十天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b65b5440958, createdName=寺牧, createdTime=Fri Apr 22 16:11:40 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209252, encodeId=89821209252bb, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：这家投稿基本都会被要求润色和证明。主编的决定也挺无厘头的，水平有待提高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 15:56:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209254, encodeId=760d12092541a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝病 经验分享：要求润色和证明，主编的拒绝挺无厘头的，观点很牵强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eab8103523, createdName=ms1000000430162409, createdTime=Thu Apr 07 16:05:18 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204455, encodeId=e617120445547, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：对自己人不友好，典型崇洋媚外, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Sun Mar 20 22:34:28 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074238, encodeId=fb7010e4238c1, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：Hepatology 经验分享：入选了国家卓越医学期刊，肝脏领域比较有前景的期刊，整个投稿过程比较严谨，2个审稿人给了比较好的建议，希望杂志越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJKjqfzvRpdPd3paICia8h4ZZ265Gh1OicXibv59LiazBkQRdIfstUSYhpejKGhKsBNLpPPeG2icQ9Zadw/132, createdBy=e6142146148, createdName=浩曦, createdTime=Fri Nov 26 14:29:10 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071922, encodeId=d9c810e1922cb, content=偏重的研究方向：肝病HBL;肝病 经验分享：知名期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:25:01 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069917, encodeId=e3b9106991e45, content=国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a98c3259782, createdName=12d1596dm99暂无昵称, createdTime=Sat Nov 13 17:15:42 CST 2021, time=2021-11-13, status=1, ipAttribution=)]

2021-11-13 12d1596dm99暂无昵称

国内期刊，主编是在美华人。杂志审稿速度一般，3个月左右，3个外审1个编辑1个主编，主编水平有待商榷，修回时外审都没意见了，主编一票否决，提前的问题极水，对华人不怎么友好，看发的文章质量也就那样，自己人的文章不少

162 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务